Hyperfine, Inc. (HYPR)
0.755
+0.06
(+9.04%)
USD |
NASDAQ |
Nov 04, 16:00
0.755
0.00 (0.00%)
After-Hours: 20:00
Hyperfine Market Cap : 80.06M for Nov. 4, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 03, 2026 | 73.42M |
| November 02, 2026 | 76.85M |
| October 30, 2026 | 76.10M |
| October 29, 2026 | 78.85M |
| October 28, 2026 | 83.20M |
| October 27, 2026 | 79.50M |
| October 26, 2026 | 76.69M |
| October 23, 2026 | 76.82M |
| October 22, 2026 | 76.97M |
| October 21, 2026 | 79.14M |
| October 20, 2026 | 82.08M |
| October 19, 2026 | 82.42M |
| October 16, 2026 | 80.04M |
| October 15, 2026 | 82.72M |
| October 14, 2026 | 84.84M |
| October 13, 2026 | 90.30M |
| October 12, 2026 | 96.12M |
| October 09, 2026 | 98.69M |
| October 08, 2026 | 99.69M |
| October 07, 2026 | 90.03M |
| October 06, 2026 | 92.26M |
| October 05, 2026 | 93.63M |
| October 02, 2026 | 94.78M |
| October 01, 2026 | 92.44M |
| September 30, 2026 | 85.68M |
| Date | Value |
|---|---|
| September 29, 2026 | 85.36M |
| September 28, 2026 | 88.64M |
| September 25, 2026 | 86.24M |
| September 24, 2026 | 84.40M |
| September 23, 2026 | 83.77M |
| September 22, 2026 | 85.38M |
| September 21, 2026 | 82.83M |
| September 18, 2026 | 83.21M |
| September 17, 2026 | 81.95M |
| September 16, 2026 | 82.10M |
| September 15, 2026 | 84.96M |
| September 14, 2026 | 85.26M |
| September 11, 2026 | 83.78M |
| September 10, 2026 | 83.39M |
| September 09, 2026 | 83.87M |
| September 08, 2026 | 87.15M |
| September 04, 2026 | 86.24M |
| September 03, 2026 | 88.76M |
| September 02, 2026 | 85.47M |
| September 01, 2026 | 85.97M |
| August 31, 2026 | 87.41M |
| August 28, 2026 | 88.35M |
| August 27, 2026 | 89.65M |
| August 26, 2026 | 92.06M |
| August 25, 2026 | 92.24M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Glaukos Corp. | 14.59B |
| Abbott Laboratories | 199.95B |
| AngioDynamics, Inc. | 519.27M |
| Alphatec Holdings, Inc. | 1.270B |
| AtriCure, Inc. | 3.329B |
Market Cap Related Metrics
| PS Ratio | 4.231 |
| Price to Book Value | 2.178 |
| Price | 0.755 |
| Earnings Yield | -50.82% |